Published in Biol Psychiatry on January 17, 2007
Effects of Cannabidiol (CBD) on the Brain (CBD) | NCT04831294
An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. J Addict Med (2011) 2.06
Effects of cannabis on neurocognitive functioning: recent advances, neurodevelopmental influences, and sex differences. Neuropsychol Rev (2012) 1.67
Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings. PLoS One (2013) 1.59
Cannabis use is quantitatively associated with nucleus accumbens and amygdala abnormalities in young adult recreational users. J Neurosci (2014) 1.41
Prefrontal cortex morphometry in abstinent adolescent marijuana users: subtle gender effects. Addict Biol (2009) 1.29
Cannabidiol attenuates the appetitive effects of Delta 9-tetrahydrocannabinol in humans smoking their chosen cannabis. Neuropsychopharmacology (2010) 1.19
Abnormal cerebellar morphometry in abstinent adolescent marijuana users. Psychiatry Res (2010) 1.18
Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction. Ann N Y Acad Sci (2010) 1.17
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. Philos Trans R Soc Lond B Biol Sci (2012) 1.15
The effect of cannabis on the brain: can it cause brain anomalies that lead to increased risk for schizophrenia? Curr Opin Psychiatry (2008) 0.95
Effects of cannabis on impulsivity: a systematic review of neuroimaging findings. Curr Pharm Des (2014) 0.92
Neurochemical alterations in adolescent chronic marijuana smokers: a proton MRS study. Neuroimage (2011) 0.92
N-acetylaspartate (NAA) correlates inversely with cannabis use in a frontal language processing region of neocortex in MDMA (Ecstasy) polydrug users: a 3 T magnetic resonance spectroscopy study. Pharmacol Biochem Behav (2008) 0.92
Cannabinoids and Schizophrenia: Risks and Therapeutic Potential. Neurotherapeutics (2015) 0.91
Preliminary evidence for white matter metabolite differences in marijuana-dependent young men using 2D J-resolved magnetic resonance spectroscopic imaging at 4 Tesla. Psychiatry Res (2011) 0.89
Modulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addiction. Front Psychiatry (2013) 0.88
Glutamate, N-acetyl aspartate and psychotic symptoms in chronic ketamine users. Psychopharmacology (Berl) (2013) 0.87
Decreased frontal N-acetylaspartate levels in adolescents concurrently using both methamphetamine and marijuana. Behav Brain Res (2013) 0.85
Effects of cannabis and familial loading on subcortical brain volumes in first-episode schizophrenia. Eur Arch Psychiatry Clin Neurosci (2013) 0.84
The effect of cannabis use on memory function: an update. Subst Abuse Rehabil (2013) 0.83
Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence. Subst Abuse (2015) 0.80
γ-Amino butyric acid and glutamate abnormalities in adolescent chronic marijuana smokers. Drug Alcohol Depend (2013) 0.80
Marijuana use trajectories and academic outcomes among college students. Drug Alcohol Depend (2016) 0.79
Telling true from false: cannabis users show increased susceptibility to false memories. Mol Psychiatry (2015) 0.77
In vivo (1)H magnetic resonance spectroscopy in young-adult daily marijuana users. Neuroimage Clin (2013) 0.77
Altered subjective reward valuation among drug-deprived heavy marijuana users: Aversion to uncertainty. J Abnorm Psychol (2015) 0.77
Neuroimaging of the dopamine/reward system in adolescent drug use. CNS Spectr (2015) 0.76
The Psychosis Recent Onset GRoningen Survey (PROGR-S): defining dimensions and improving outcomes in early psychosis. PLoS One (2014) 0.76
The impact of marijuana use on memory in HIV-infected patients: a comprehensive review of the HIV and marijuana literatures. Curr Drug Abuse Rev (2016) 0.75
Safety and Toxicology of Cannabinoids. Neurotherapeutics (2015) 0.75
N-acetyl aspartate levels in adolescents with bipolar and/or cannabis use disorders. J Dual Diagn (2014) 0.75
Frontal Metabolite Concentration Deficits in Opiate Dependence Relate to Substance Use, Cognition, and Self-Regulation. J Addict Res Ther (2016) 0.75
Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA (2007) 6.81
A genome-wide association study of alcohol dependence. Proc Natl Acad Sci U S A (2010) 4.94
Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat Neurosci (2004) 3.56
Genome-wide association study of alcohol dependence. Arch Gen Psychiatry (2009) 3.08
Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving. Am J Psychiatry (2004) 2.84
Remission of major depression under deep brain stimulation of the lateral habenula in a therapy-refractory patient. Biol Psychiatry (2010) 2.71
Cue-induced activation of the striatum and medial prefrontal cortex is associated with subsequent relapse in abstinent alcoholics. Psychopharmacology (Berl) (2004) 2.69
A bibliometric analysis of European versus USA research in the field of addiction. Research on alcohol, narcotics, prescription drug abuse, tobacco and steroids 2001-2011. Eur Addict Res (2013) 2.22
Focus on ECT seizure quality: serum BDNF as a peripheral biomarker in depressed patients. Eur Arch Psychiatry Clin Neurosci (2014) 2.18
Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J Neurosci (2005) 2.04
New evidence for seizure quality improvement by hyperoxia and mild hypocapnia. J ECT (2014) 2.03
Adolescent impulsivity phenotypes characterized by distinct brain networks. Nat Neurosci (2012) 1.98
The effect of computerized tailored brief advice on at-risk drinking in subcritically injured trauma patients. J Trauma (2006) 1.77
Severity of nicotine dependence modulates cue-induced brain activity in regions involved in motor preparation and imagery. Psychopharmacology (Berl) (2005) 1.76
Medicinal Δ(9) -tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests. Addiction (2012) 1.65
Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians. Hepatology (2010) 1.65
Gender differences in the processing of standardized emotional visual stimuli in humans: a functional magnetic resonance imaging study. Neurosci Lett (2003) 1.63
Alcohol and the human brain: a systematic review of different neuroimaging methods. Alcohol Clin Exp Res (2011) 1.60
Amygdala volume associated with alcohol abuse relapse and craving. Am J Psychiatry (2008) 1.56
Risk taking and the adolescent reward system: a potential common link to substance abuse. Am J Psychiatry (2011) 1.56
Initial, habitual and compulsive alcohol use is characterized by a shift of cue processing from ventral to dorsal striatum. Addiction (2010) 1.52
The place of additional individual psychotherapy in the treatment of alcoholism: a randomized controlled study in nonresponders to anticraving medication-results of the PREDICT study. Alcohol Clin Exp Res (2013) 1.52
Correlation of alcohol craving with striatal dopamine synthesis capacity and D2/3 receptor availability: a combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patients. Am J Psychiatry (2005) 1.41
Treating alcoholism reduces financial burden on care-givers and increases quality-adjusted life years. Addiction (2012) 1.39
Systematic analysis of glutamatergic neurotransmission genes in alcohol dependence and adolescent risky drinking behavior. Arch Gen Psychiatry (2008) 1.39
Genome-wide significant association between alcohol dependence and a variant in the ADH gene cluster. Addict Biol (2011) 1.37
Brain activation elicited by affectively positive stimuli is associated with a lower risk of relapse in detoxified alcoholic subjects. Alcohol Clin Exp Res (2007) 1.37
Serotonin transporter genotype (5-HTTLPR): effects of neutral and undefined conditions on amygdala activation. Biol Psychiatry (2006) 1.35
Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial. Arch Intern Med (2008) 1.34
Effect of brain structure, brain function, and brain connectivity on relapse in alcohol-dependent patients. Arch Gen Psychiatry (2012) 1.30
Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil. Arch Gen Psychiatry (2005) 1.29
A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence. Eur Neuropsychopharmacol (2013) 1.27
Alcoholic neurobiology: changes in dependence and recovery. Alcohol Clin Exp Res (2005) 1.24
Effects of cue-exposure treatment on neural cue reactivity in alcohol dependence: a randomized trial. Biol Psychiatry (2011) 1.21
Translational magnetic resonance spectroscopy reveals excessive central glutamate levels during alcohol withdrawal in humans and rats. Biol Psychiatry (2011) 1.18
Pregabalin abuse, dependence, and withdrawal: a case report. Am J Psychiatry (2010) 1.18
Cue exposure in the treatment of alcohol dependence: effects on drinking outcome, craving and self-efficacy. Br J Clin Psychol (2006) 1.16
Reward craving and withdrawal relief craving: assessment of different motivational pathways to alcohol intake. Alcohol Alcohol (2003) 1.16
Alcoholism in women: is it different in onset and outcome compared to men? Eur Arch Psychiatry Clin Neurosci (2007) 1.13
Monitoring the effects of chronic alcohol consumption and abstinence on brain metabolism: a longitudinal proton magnetic resonance spectroscopy study. Biol Psychiatry (2005) 1.13
Gender differences in the performance of a computerized version of the alcohol use disorders identification test in subcritically injured patients who are admitted to the emergency department. Alcohol Clin Exp Res (2004) 1.12
Net influx of plasma 6-[18F]fluoro-L-DOPA (FDOPA) to the ventral striatum correlates with prefrontal processing of affective stimuli. Eur J Neurosci (2006) 1.10
Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective study. Eur Arch Psychiatry Clin Neurosci (2011) 1.10
Blockade of cue-induced brain activation of abstinent alcoholics by a single administration of amisulpride as measured with fMRI. Alcohol Clin Exp Res (2006) 1.09
Cost-effective primary care-based strategies to improve smoking cessation: more value for money. Arch Intern Med (2009) 1.09
Impairment of cognitive abilities and decision making after chronic use of alcohol: the impact of multiple detoxifications. Alcohol Alcohol (2009) 1.09
Impact of the anesthetic agents ketamine, etomidate, thiopental, and propofol on seizure parameters and seizure quality in electroconvulsive therapy: a retrospective study. Eur Arch Psychiatry Clin Neurosci (2013) 1.09
Diminished gray matter in the hippocampus of cannabis users: possible protective effects of cannabidiol. Drug Alcohol Depend (2010) 1.08
Laparoscopic fluorescence diagnosis for intraabdominal fluorescence targeting of peritoneal carcinosis experimental studies. Ann Surg (2002) 1.07
An integrated genome research network for studying the genetics of alcohol addiction. Addict Biol (2010) 1.07
Efficacy of as-needed nalmefene in alcohol-dependent patients with at least a high drinking risk level: results from a subgroup analysis of two randomized controlled 6-month studies. Alcohol Alcohol (2013) 1.05
Determinants of early alcohol use in healthy adolescents: the differential contribution of neuroimaging and psychological factors. Neuropsychopharmacology (2011) 1.03
Fatal and severe codeine intoxication in 3-year-old twins--interpretation of drug and metabolite concentrations. Int J Legal Med (2009) 1.03
Correlation of glutamate levels in the anterior cingulate cortex with self-reported impulsivity in patients with borderline personality disorder and healthy controls. Arch Gen Psychiatry (2010) 1.01
HPA-axis activity in alcoholism: examples for a gene-environment interaction. Addict Biol (2007) 1.01
In vivo voxel based morphometry: detection of increased hippocampal volume and decreased glutamate levels in exercising mice. Neuroimage (2012) 1.01
Alcohol consumption significantly influences the MR signal of frontal choline-containing compounds. Neuroimage (2006) 1.01
Decision making of heavy cannabis users on the Iowa Gambling Task: stronger association with THC of hair analysis than with personality traits of the Tridimensional Personality Questionnaire. Eur Addict Res (2009) 0.99
Identifying the gap between need and intervention for alcohol use disorders in Europe. Addiction (2011) 0.99
Orexin and leptin are associated with nicotine craving: a link between smoking, appetite and reward. Psychoneuroendocrinology (2009) 0.99
Effects of dexamphetamine with and without alcohol on simulated driving. Psychopharmacology (Berl) (2011) 0.98
Acamprosate: how, where, and for whom does it work? Mechanism of action, treatment targets, and individualized therapy. Curr Pharm Des (2010) 0.98
Effects of alcoholism and continued abstinence on brain volumes in both genders. Alcohol Clin Exp Res (2011) 0.98
Validating incentive salience with functional magnetic resonance imaging: association between mesolimbic cue reactivity and attentional bias in alcohol-dependent patients. Addict Biol (2011) 0.98
Attentional bias in alcohol-dependent patients: the role of chronicity and executive functioning. Addict Biol (2009) 0.98
Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study. J Clin Psychopharmacol (2002) 0.98
The Alcohol Clinical Trials Initiative (ACTIVE): purpose and goals for assessing important and salient issues for medications development in alcohol use disorders. Neuropsychopharmacology (2011) 0.96
Severity of dependence modulates smokers' neuronal cue reactivity and cigarette craving elicited by tobacco advertisement. Addict Biol (2011) 0.96
Low efficacy of non-opioid drugs in opioid withdrawal symptoms. Addict Biol (2005) 0.95
Functioning and neuronal viability of the anterior cingulate neurons following antipsychotic treatment: MR-spectroscopic imaging in chronic schizophrenia. Eur Neuropsychopharmacol (2002) 0.95
Multicentre variability of MRI-based medial temporal lobe volumetry in Alzheimer's disease. Psychiatry Res (2010) 0.95
Electroconvulsive therapy induces neurogenesis in frontal rat brain areas. PLoS One (2013) 0.94
Aspartoacylase-lacZ knockin mice: an engineered model of Canavan disease. PLoS One (2011) 0.94
Dysregulation of the hypothalamic-pituitary-thyroid axis in alcoholism. Addiction (2002) 0.94
Drinking against unpleasant emotions: possible outcome of early onset of alcohol use? Alcohol Clin Exp Res (2010) 0.94
Rapid partial regeneration of brain volume during the first 14 days of abstinence from alcohol. Alcohol Clin Exp Res (2012) 0.94
Candidate genes for alcohol dependence: animal studies. Alcohol Clin Exp Res (2003) 0.94
Effects of a manualized short-term treatment of internet and computer game addiction (STICA): study protocol for a randomized controlled trial. Trials (2012) 0.93
Chronic alcohol consumption, abstinence and relapse: brain proton magnetic resonance spectroscopy studies in animals and humans. Curr Top Behav Neurosci (2013) 0.93
LC-MS/MS analysis of phosphatidylethanol in dried blood spots versus conventional blood specimens. Anal Bioanal Chem (2011) 0.93
Analysis of genetic variations of protein tyrosine kinase fyn and their association with alcohol dependence in two independent cohorts. Biol Psychiatry (2003) 0.92